弥漫大B细胞淋巴瘤患者DKK-1、β-catenin、Caspase 3蛋白表达水平的变化及意义

doi:10.3969/j.issn.1671-7171.2021.10.034

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1160 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To observe the expression of DKK-1, β-catenin and caspase 3 in patients with diffuse large B-cell lymphoma (DLBCL) and analyze the influencing factors. 【Methods】The patients with DLBCL who were treated in our hospital from February 2014 to August 2019were enrolled. The expressions of DKK-1, β-catenin and caspase 3 in cancer tissues and paracancerous tissues of patients with DLBCL were detected and their effects were analyzed. 【Results】The positive expression rates of DKK-1, β-catenin and caspase 3 in cancer tissues of DLBCL patients were significantly higher than those in cancer adjacent tissues. The difference was statistically significant (P<0.05). The clinical stage in Ⅲ+Ⅳ, PS score ≥2, and IDH increased. The positive expression rates of DKK-1, β-catenin and caspase 3 in DLBCL patients with clinical stage Ⅲ+Ⅳ, PS (performance status) score ≥2, high IDH (isocitrate dehydrogenase), and high risk of IPI (international prognostic index) were much higher (P<0.05). There were no significant differences in the positive expression rates of DKK-1, β-catenin and caspase 3 in patients with different ages and genders. DKK- patients with DLBCL 1. Multivariate logistica repression showed that clinical stage and IDH were the factors that affected the expression of DKK-1, β-catenin and caspase 3 expression in DLBCL patients (OR=4.865, 5.013). 【Conclusion】The positive expression rates of DKK-1, β-catenin and caspase 3 in patients with diffuse large B-cell lymphoma are high, which are affected by clinical stage and IDH.

Key words： Lymphoma, Large B-Cell, Diffuse/PA Beta Catenin Caspase 3

Received: 15 October 2020

PACS:

R733.41

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DING Feng-Jiao
	CAO Hong-you

Cite this article:

DING Feng-Jiao,CAO Hong-you. Significance of DKK-1, β-catenin and Caspase 3 Protein Expression in Patients with DLBCL[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(10): 1560-1562.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.10.034 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I10/1560

[1] 晋龙, 眭玉霞, 陈志忠,等. 凋亡相关蛋白Livin与Caspase-3在弥漫性大B细胞淋巴瘤中的表达及其临床意义[J].中国实验血液学杂志, 2017, 25(6):1664-1669.
[2] 濮珍红. 弥漫大B细胞淋巴瘤中miR-125a-5p的表达及其意义[J].实用医学杂志, 2017, 33(17):2864-2868.
[3] 钟瑶, 王莹莹, 杭海芳,等. 环磷酸腺苷拟似物联合硼替佐米诱导弥漫大B细胞淋巴瘤细胞凋亡作用及其机制研究[J].世界临床药物, 2017,18(5):311-317.
[4] 汪遵君. 膀胱癌灌注化疗过程中负面情绪对肿瘤负荷及抗肿瘤免疫应答的影响[J].海南医学院学报, 2017, 23(18):134.
[5] 彭攀.18F-FDG PET-CT 在结外鼻型NK/T 细胞淋巴瘤中的研究进展[J].癌症进展,2017,15(8):868-871.
[6] WU C H, YANG Y H, CHEN M R, et al. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells[J].PLoS One,2018, 13(6):199779.
[7] 宫莹莹, 何玉, 席玉玲. PARP-1、 Caspase-3在子宫内膜癌组织中的表达变化及意义[J].山东医药, 2017,18(44):92-94.
[8] GUAN J, ZHAO Q, LV J, et al. Triptolide induces DNA breaks, activates caspase-3-dependent apoptosis and sensitizes B-cell lymphoma to poly(ADP-ribose) polymerase 1 and phosphoinositide 3-kinase inhibitors[J].Oncol Lett,2017, 14(4):4965-4970.
[9] 利妥昔单抗与依鲁替尼对弥漫性大B细胞淋巴瘤细胞增殖和凋亡协同作用研究[J].中华肿瘤防治杂志, 2017, 24(8):535-539.
[10] 赵兵, 张华茹, 李杰,等. 吡非尼酮逆转博来霉素诱导大鼠PIF的疗效及对TGF-β1、caspase-3的影响[J].临床肺科杂志, 2018, 23(7):1240-1244.
[11] ZHANG Z C, LIU J X, SHAO Z W, et al.In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.[J].Medicine,2017, 96(27):e7245.
[12] 王佳鑫, 段远胜, 岳恺,等. MALAT1通过VHL/β-catenin通路影响口腔鳞状细胞癌生长侵袭的实验研究[J].中国肿瘤临床, 2017, 44(9):418-423.